Intrust Bank NA Grows Holdings in Fresenius Medical Care Corporation (FMS)

Intrust Bank NA grew its holdings in Fresenius Medical Care Corporation (NYSE:FMS) by 21.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,865 shares of the company’s stock after purchasing an additional 2,934 shares during the quarter. Intrust Bank NA’s holdings in Fresenius Medical Care Corporation were worth $825,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Harding Loevner LP lifted its stake in Fresenius Medical Care Corporation by 6.2% in the 2nd quarter. Harding Loevner LP now owns 3,748,173 shares of the company’s stock worth $181,149,000 after purchasing an additional 219,213 shares in the last quarter. Cambiar Investors LLC lifted its stake in Fresenius Medical Care Corporation by 3.2% in the 2nd quarter. Cambiar Investors LLC now owns 2,596,480 shares of the company’s stock worth $125,488,000 after purchasing an additional 80,064 shares in the last quarter. Royal Bank of Canada lifted its stake in Fresenius Medical Care Corporation by 6.4% in the 2nd quarter. Royal Bank of Canada now owns 501,694 shares of the company’s stock worth $24,248,000 after purchasing an additional 30,119 shares in the last quarter. US Bancorp DE lifted its stake in Fresenius Medical Care Corporation by 10.4% in the 2nd quarter. US Bancorp DE now owns 427,021 shares of the company’s stock worth $20,637,000 after purchasing an additional 40,121 shares in the last quarter. Finally, Parametric Portfolio Associates LLC lifted its stake in Fresenius Medical Care Corporation by 8.2% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 399,706 shares of the company’s stock worth $19,318,000 after purchasing an additional 30,140 shares in the last quarter. 2.62% of the stock is currently owned by institutional investors and hedge funds.

Several analysts have recently commented on FMS shares. Royal Bank Of Canada reaffirmed a “hold” rating and set a $44.00 price target on shares of Fresenius Medical Care Corporation in a research report on Wednesday, September 13th. Zacks Investment Research lowered shares of Fresenius Medical Care Corporation from a “buy” rating to a “sell” rating in a research report on Wednesday, October 25th. DZ Bank AG reaffirmed a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Monday, August 7th. Finally, BidaskClub lowered shares of Fresenius Medical Care Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. Fresenius Medical Care Corporation has an average rating of “Hold” and a consensus price target of $48.50.

Fresenius Medical Care Corporation (NYSE FMS) traded down $0.39 during mid-day trading on Monday, hitting $48.42. 97,000 shares of the stock traded hands, compared to its average volume of 183,419. The stock has a market cap of $29,813.26, a price-to-earnings ratio of 21.71, a PEG ratio of 2.18 and a beta of 0.45. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55. Fresenius Medical Care Corporation has a 1 year low of $38.05 and a 1 year high of $50.22.

WARNING: This article was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/11/13/intrust-bank-na-grows-holdings-in-fresenius-medical-care-corporation-fms.html.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply